ADBIOTECH Corrects Terms for 30 Billion Won Convertible Bond Issuance
ADBIOTECH has decided to issue unregistered private convertible bonds totaling 6 billion won, 3 billion won each to its largest shareholder BK Partners Investment Union No.1 and Awesome D Investment Union, with amendments to payment date, maturity, and conversion price compared to the initial filing.
The revised conversion prices are 2,495 won and 2,264 won per share, slightly above the current price of 2,310 won, and conversion would result in approximately 1.20 million and 1.33 million new shares, representing 5.76% and 6.31% of outstanding shares respectively. Combined with existing convertible bonds, total potential dilution reaches about 38%, raising significant concern for existing shareholder value.
The proceeds are slated for acquisition of securities of other corporations, but the specific target remains undetermined. The bonds carry a 0% coupon and 3% yield to maturity with principal repayment at 115.93% at maturity, along with a put option for early redemption.
Governance risks include the audit opinion of Itron, the sole investor of BK Partners, being disclaimed, and Awesome D Investment Union providing no financial disclosure.
[AI Summary]ADBIOTECH's 6 billion won CB issuance via private placement to its largest shareholder involves conversion prices close to the market price, implying meaningful dilution risk. The opaque use of funds and questionable counterparty financial health warrant investor caution.
KOSDAQ Filing Information
[Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)